会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 호흡기 신시티움 바이러스에 대한 항체
    • 抗呼吸道感染病毒的抗体
    • KR1020090076213A
    • 2009-07-13
    • KR1020080002023
    • 2008-01-08
    • (주) 에이프로젠
    • 김근수전춘주임남규김세연이상윤주혜경
    • C07K16/08C07K16/00
    • C07K16/1027A61K2039/505C07K2317/21C07K2317/54C07K2317/55C07K2317/56C07K2317/76
    • A pharmaceutical composition for preventing and treating respiratory syncytial virus(RSV) infection is provided to have excellent prevention effect to in vivo infection. An antibody against respiratory syncytial virus comprises light chain variation area having a heavy chain CDR (complementarity determining region) amino acid sequence comprising CDRH1 of the sequence number 31, CDRH2 of the sequence number 32, or CDRH3 of the sequence number 33. A method for producing the antibody against the respiratory syncytial virus comprises: a step of culturing a host cell which is transformed with a recombinant vector containing nucleic acid molecule which codes an antibody; and a step of expressing the antibody. A composition for preventing and treating respiratory syncytial virus infection comprises pharmaceutically active amount of antibody against the respiratory syncytial virus and pharmaceutically allowable carrier.
    • 提供了用于预防和治疗呼吸道合胞病毒(RSV)感染的药物组合物以对体内感染具有优异的预防作用。 针对呼吸道合胞病毒的抗体包含具有包含序列号31的CDRH1,序列号32的CDRH2或序列号33的CDRH3的重链CDR(互补决定区)氨基酸序列的轻链变异区。 产生针对呼吸道合胞病毒的抗体包括:培养用含有编码抗体的核酸分子的重组载体转化的宿主细胞的步骤; 和表达该抗体的步骤。 用于预防和治疗呼吸道合胞病毒感染的组合物包含针对呼吸道合胞病毒和药学上可允许的载体的药学活性量的抗体。